Chinese Journal of Magnetic Resonance ›› 2017, Vol. 34 ›› Issue (3): 302-310.doi: 10.11938/cjmr20172558

Previous Articles     Next Articles

A New Gd-Based T2-Weighted Magnetic Resonance Imaging Contrast Agent:Preparation and Application in Stem Cell Imaging

ZHANG Yan-hui1,2, ZHANG Hong-yan2, ZHANG Hai-lu2, ZHANG Peng-li1,2, JIANG Hai-zhen1, DENG Zong-wu2, TAN Bo2   

  1. 1. College of Sciences, Shanghai University, Shanghai 200444, China;
    2. Suzhou Institute of Nano-tech and Nano-bionics, Chinese Academy of Sciences, Suzhou 215123, China
  • Received:2017-02-04 Revised:2017-07-21 Online:2017-09-05 Published:2017-09-05

Abstract: We synthesized TPP-Lys(Acp-DOTA-Gd)-COOH (Gd-DOTA-TPP) as a novel T2-weighted MRI contrast agent, and used it to label human mesenchymal stem cells (hMSCs) via electroporation. hMSCs labeled with Gd-DOTA-TPP presented a rather dark T2-weighted image at a cellular Gd content of about 9×109 Gd/cell. The labeled cells were syringe-injected into a mouse brain with defined cell numbers followed by T2-weighted MRI on an 11.7 T system, which yield an in vivo imaging sensitivity of about 103 cells.

Key words: contrast agent, human mesenchymal stem cells (hMSCs), magnetic resonance imaging (MRI), TPP-Lys(Acp-DOTA-Gd)-COOH (Gd-DOTA-TPP), sensitivity

CLC Number: